Mass Tort Cases

 

What We Do

“Every case is prepared for victory at trial.  We litigate to win and will not be out-worked or out-fought in our pusuit for just compensation.”

 

Fentanyl Patches Recalled

February 15, 2008

On February 12, 2008, PriCara announced that patches containing the prescription painkiller "fentanyl" are being recalled.  According to the PriCara Web site, the 25 microgram-per-hour fentanyl patches are being recalled due to potentially fatal flaws that could result in a lethal overdose to patients.  Fentanyl is a potent Schedule II opioid medication, and exposure to fentanyl gel can lead to very serious adverse events, including respiratory depression and death.

According to the PriCara Web site, the 25 mcg patches recalled may have a cut along one side of the drug reservoir within the patch, potentially exposing patients to a potentially fatal overdose of fentanyl.  The patches have been sold in the United Stated under the brand name "Duragesic" by PriCara.  Generic versions were sold by Sandoz, Incorporated.  All of the recalled patches have expiration dates on or before December of 2009, and were manufactured by a PriCara affiliate, the ALZA Corporation, which is a division of Ortho-McNeil-Janssen Pharmaceuticals, Incorporated.  PriCara, the ALZA Corporation and Ortho-McNeil-Janssen are all subsidiaries of the Johnson & Johnson Company.

Previously, in July of 2005, the FDA issued an advisory emphasizing the limited safe uses of the fentanyl patch.  Despite the advisory, the FDA apparently continued to receive reports of death and life-threatening events in patients who suffered overdoses while using the fentanyl patches, and the FDA issued an updated advisory on December 21, 2007.  In the Advisory, the FDA stated that the fentanyl patch "is only indicated for use in patients with persistent, moderate to severe chronic pain who have been taking a regular, daily, around-the-clock narcotic pain medicine for longer than a week and are considered to be opioid-tolerant."

If you wish to speak to us about a potential claim or an injury caused by Fantanyl Patches. The attorneys at Paris & Chaikin, PLLC, are available to answer your questions. Consultations are free with no obligations. CALL OUR FIRM TODAY AT 212-742-0476.

Paris & Chaikin, PLLC is a New York based boutique personal injury law firm committed to representing innocent - Read More >
 
We are honored to represent a diverse client base in their quest for just compensation - Read More >
 
Paris & Chaikin, PLLC attorneys are experienced and aggressive, and represent those seriously injured - Read More >

Recent News & Current Events

Sat, 04 Sep 2010 12:17:00 -0700
Thousands Of Returning Soldiers Face A New Enemy
The legacy of one of America's longest combat missions will continue to affect the thousands of troops who came home suffering from post-traumatic stress disorder and traumatic brain injuries.

Sat, 04 Sep 2010 12:17:00 -0700
Mental Stimulation Postpones, Then Speeds Dementia
Keeping an active mind helps stave off the development of dementia. But being mentally active might speed up Alzheimer's once it hits, according to new research from Chicago's Rush University Medical Center.

Sat, 04 Sep 2010 12:17:00 -0700
What You Can Do For Health Care This Weekend? Fix It
Your bright ideas for cutting the cost of health care could earn you some money. A group that's trying to raise health professionals' awareness about costs is holding an essay contest to find the best suggestions.

Sat, 04 Sep 2010 12:17:00 -0700
Health Law Myths: Outside The Realm Of Reality
Are you really going to have to have a computer chip implanted in your head as part of the new health law? Will the law allow President Obama to create his own private army? While there are outrageous rumors circulating about the health law, some claims are grounded in truth.

Sat, 04 Sep 2010 12:17:00 -0700
Bosses Put Higher Insurance Tab On Workers' Shoulders
Employers keep shifting a larger share of health costs to their employees. Higher premiums, deductibles and copayments are making health insurance less affordable for people who get coverage at work.